Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)
CAPS Rating:
A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases
A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
took to much of a beating on hep-c trial news. should outperform.